• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应对21世纪的心力衰竭问题。

Tackling heart failure in the twenty-first century.

作者信息

Mudd James O, Kass David A

机构信息

Johns Hopkins Medical Institutions, 720 Rutland Avenue, Ross 835, Baltimore, Maryland 21205, USA.

出版信息

Nature. 2008 Feb 21;451(7181):919-28. doi: 10.1038/nature06798.

DOI:10.1038/nature06798
PMID:18288181
Abstract

Heart failure, or congestive heart failure, is a condition in which the heart cannot supply the body's tissues with enough blood. The result is a cascade of changes that lead to severe fatigue, breathlessness and, ultimately, death. In the past quarter century, much progress has been made in understanding the molecular and cellular processes that contribute to heart failure, leading to the development of effective therapies. Despite this, chronic heart failure remains a major cause of illness and death. And because the condition becomes more common with increasing age, the number of affected individuals is rising with the rapidly ageing global population. New treatments that target disease mechanisms at the cellular and whole-organ level are needed to halt and reverse the devastating consequences of this disease.

摘要

心力衰竭,即充血性心力衰竭,是一种心脏无法为身体组织提供足够血液的病症。其结果是一系列导致严重疲劳、呼吸急促并最终导致死亡的变化。在过去的四分之一世纪里,在理解导致心力衰竭的分子和细胞过程方面取得了很大进展,从而促成了有效疗法的开发。尽管如此,慢性心力衰竭仍然是疾病和死亡的主要原因。而且由于这种病症随着年龄增长而变得更加常见,随着全球人口迅速老龄化,受影响个体的数量正在上升。需要在细胞和全器官水平上针对疾病机制的新疗法来阻止和扭转这种疾病的毁灭性后果。

相似文献

1
Tackling heart failure in the twenty-first century.应对21世纪的心力衰竭问题。
Nature. 2008 Feb 21;451(7181):919-28. doi: 10.1038/nature06798.
2
Gene therapy for heart failure.心力衰竭的基因治疗。
Semin Thorac Cardiovasc Surg. 2005 Winter;17(4):343-7. doi: 10.1053/j.semtcvs.2005.09.002.
3
The right heart and its distinct mechanisms of development, function, and failure.右心及其独特的发育、功能和衰竭机制。
J Surg Res. 2008 May 15;146(2):304-13. doi: 10.1016/j.jss.2007.04.003. Epub 2007 Nov 26.
4
[Experience and prospects in the treatment of heart failure].[心力衰竭治疗的经验与展望]
Therapie. 2009 Mar-Apr;64(2):75-80. doi: 10.2515/therapie/2009026. Epub 2009 Aug 11.
5
Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure.心脏肥大向心力衰竭转变的分子机制。
Circ J. 2008;72 Suppl A:A13-6. doi: 10.1253/circj.cj-08-0481. Epub 2008 Sep 5.
6
New therapies in acute decompensated heart failure.急性失代偿性心力衰竭的新疗法
Curr Opin Cardiol. 2008 Mar;23(2):134-40. doi: 10.1097/HCO.0b013e3282f798be.
7
[New pharmacological approaches in heart failure: should we treat the endothelium?].
Therapie. 2009 Mar-Apr;64(2):93-100. doi: 10.2515/therapie/2009014. Epub 2009 Aug 11.
8
Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.无症状左心室功能障碍或慢性心力衰竭的心肌梗死幸存者的主要不良心脏事件预测因素
Med Sci Monit. 2009 Jun;15(6):PH40-8.
9
Total artificial heart--concepts and clinical use.全人工心脏——概念与临床应用。
Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):247-54. doi: 10.1053/j.semtcvs.2008.08.006.
10
Strategies for the treatment of acute heart failure in children.儿童急性心力衰竭的治疗策略
Minerva Cardioangiol. 2008 Jun;56(3):321-33.

引用本文的文献

1
Heart failure-specific cardiac fibroblasts contribute to cardiac dysfunction via the MYC-CXCL1-CXCR2 axis.心力衰竭特异性心肌成纤维细胞通过MYC-CXCL1-CXCR2轴导致心脏功能障碍。
Nat Cardiovasc Res. 2025 Sep 10. doi: 10.1038/s44161-025-00698-y.
2
The methylation of TXNRD2 with chronic heart failure: the interaction effect between methylation regulation and clinical parameters-- a single center pilot study.慢性心力衰竭中TXNRD2的甲基化:甲基化调控与临床参数之间的相互作用——一项单中心试点研究。
BMC Cardiovasc Disord. 2025 Aug 21;25(1):622. doi: 10.1186/s12872-025-04951-x.
3
S100A4-shRNA mitigates autophagy, reduces inflammation, and improves cardiac functionality in MIRI.
S100A4短发夹RNA减轻心肌缺血再灌注损伤中的自噬、减轻炎症并改善心脏功能。
Int J Cardiol Cardiovasc Risk Prev. 2025 May 29;26:200443. doi: 10.1016/j.ijcrp.2025.200443. eCollection 2025 Sep.
4
Riluzole is associated with reduced risk of heart failure.利鲁唑与降低心力衰竭风险相关。
Eur J Neurol. 2025 Jan;32(1):e70033. doi: 10.1111/ene.70033.
5
ALDH2 mediates the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on improving cardiac remodeling.ALDH2 介导钠-葡萄糖共转运蛋白 2 抑制剂 (SGLT2i) 改善心脏重构的作用。
Cardiovasc Diabetol. 2024 Oct 26;23(1):380. doi: 10.1186/s12933-024-02477-8.
6
Beta-Blockers as an Immunologic and Autonomic Manipulator in Critically Ill Patients: A Review of the Recent Literature.β受体阻滞剂在危重症患者中的免疫调节和自主神经调控作用:文献复习。
Int J Mol Sci. 2024 Jul 24;25(15):8058. doi: 10.3390/ijms25158058.
7
Status of β-Adrenoceptor Signal Transduction System in Cardiac Hypertrophy and Heart Failure.心脏肥大和心力衰竭中β-肾上腺素能受体信号转导系统的状态
Rev Cardiovasc Med. 2023 Sep 21;24(9):264. doi: 10.31083/j.rcm2409264. eCollection 2023 Sep.
8
Diabetes and Heart Failure: A Literature Review, Reflection and Outlook.糖尿病与心力衰竭:文献综述、反思与展望
Biomedicines. 2024 Jul 15;12(7):1572. doi: 10.3390/biomedicines12071572.
9
Decoding cardiogenic shock: assessing shock index and its variants as prognostic indicators for in-hospital mortality.解码心源性休克:评估休克指数及其变体作为院内死亡率的预后指标。
ESC Heart Fail. 2024 Oct;11(5):3023-3032. doi: 10.1002/ehf2.14853. Epub 2024 Jun 6.
10
Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure.血管活性激素诱导的信号转导在心肌肥厚和心力衰竭中的作用。
Cells. 2024 May 17;13(10):856. doi: 10.3390/cells13100856.